News

Article

PerkinElmer Unveils Cell Analysis Solution

PerkinElmer has unveiled a cell analysis solution to streamline cell and gene therapy research and manufacturing.

PerkinElmer announced on Sept. 26, 2022 that it has launched the Cellaca PLX Image Cytometry System, a platform designed to enable researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow; this includes cell identity, quality, and quantity.

The system combines image cytometer hardware, software, validated consumables, and trackable data reporting; it is designed to eliminate complex calibration procedures or intense training requirements. According to a company press release, the new offering will provide researchers expanded cell sample CQA analysis options beyond flow cytometry and staining methods, which have historically required a variety of different instruments and analytical methods. By combining these capabilities, researchers can detect multiple markers simultaneously and perform immunophenotyping and viability assays in seconds.

"Pharmaceutical companies have invested heavily in cell and gene therapy, but they struggle to assess the complex cell samples required to meet immense scientific demands and regulatory rigor across their research and manufacturing processes," said Alan Fletcher, senior vice-president, Life Sciences, PerkinElmer, in the release. "While the Cellaca PLX Image Cytometer platform is therapeutic area agnostic, it is expected to be especially beneficial for researchers working in CAR-T cell therapy who want to streamline their phenotyping of immune cells for downstream processes."

Source: PerkinElmer

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content